Top Markets
#1 GoPlus Security GoPlus Security +31.51%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.70%
#3 Status Status +17.55%
#4 Wrapped NXM Wrapped NXM +14.47%
#5 BankrCoin BankrCoin +11.13%
#6 Pons Pons +10.73%
#7 Bedrock Bedrock +10.01%
#8 Ontology Gas Ontology Gas +9.25%
#9 DMT-NAT DMT-NAT +8.78%
#10 o1.exchange o1.exchange +7.41%
Coin of the day
GoPlus Security GoPlus Security
Settings
Language
ENGLISH
Currency
USD
Theme
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Rank in Stocks #33997
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Share Price
$0.1502
Last synced: 2024-11-04
Market Cap
$6.43M
Change (1 day)
-5.45%
Change (1 year)
0.00%
Country
US
Trade Renalytix Plc (RNLX)

Category

Healthcare
Number of shares outstanding for Renalytix Plc (RNLX)
Number of shares outstanding as of September 2024: 52.85M
According to Renalytix Plc latest financial reports and stock price the company's current number of shares outstanding is 52.85M. At the end of June 2023 the company had 41.11M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Renalytix Plc (RNLX) from 2018 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 52.85M -2.29%
2024 54.09M 31.59%
2023 41.11M 20.93%
2022 33.99M -4.07%
2021 35.43M 22.38%
2020 28.95M 36.05%
2019 21.28M 1.82%
2018 20.90M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
GE HealthCare Technologies Inc. GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc.
GEHC.US
 453.00M 757.16%
US
Pro Medicus Limited Pro Medicus Limited
Pro Medicus Limited
PME.AX
 104.48M 97.70%
AU
BrightSpring Health Services, Inc. Common Stock BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. Common Stock
BTSG.US
 205.38M 288.62%
US
Tempus AI, Inc. Tempus AI, Inc.
Tempus AI, Inc.
TEM.US
 179.92M 240.44%
US
Signify Health, Inc. Signify Health, Inc.
Signify Health, Inc.
SGFY.US
 - -
US